David P. Bonita - Jun 6, 2024 Form 4 Insider Report for Third Harmonic Bio, Inc. (THRD)

Role
Director
Signature
/s/ Christopher Murphy, Attorney-in-Fact
Stock symbol
THRD
Transactions as of
Jun 6, 2024
Transactions value $
$0
Form type
4
Date filed
6/10/2024, 04:20 PM
Previous filing
Sep 21, 2023
Next filing
Jun 10, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction THRD Director Stock Option (right to buy) Award $0 +20K $0.00 20K Jun 6, 2024 Common Stock 20K $13.85 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option will vest in full on the earlier of (a) June 6, 2025 and (b) the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's provision of service to the Issuer on the vesting date.
F2 Pursuant to an agreement with OrbiMed Advisors LLC and OrbiMed Capital GP VII LLC, the Reporting Person is obligated to transfer any securities issued under any such stock options or other awards, or the economic benefit thereof, to OrbiMed Advisors LLC and OrbiMed Capital GP VII LLC, which will in turn ensure that such securities or economic benefits are provided to OrbiMed Private Investments VII, LP.